Ekso Bionics Announces Third Quarter 2024 Financial Results
Ekso Bionics Holdings, Inc. (EKSO)
NASDAQ:AMEX Investor Relations:
ir.eksobionics.com
Company Research
Source: GlobeNewswire
SAN RAFAEL, Calif., Oct. 28, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today reported financial results for the three and nine months ended September 30, 2024. Recent Highlights and Accomplishments Reported revenue of $4.1 million in the third quarter of 2024Sold a total of 33 EksoHealth devices in the third quarter of 2024Announced receipt of initial Centers for Medicare & Medicaid Services (“CMS”) reimbursement for Ekso Indego PersonalAchieved gross margin of 53.5% in the third quarter of 2024Completed underwritten offering resulting in net proceeds of approximately $5.0 million in September 2024 “The receipt of initial CMS reimbursement through our Durable Medical Equipment Medicare Administrative Contractors (“DMEs”) for our Ekso Indego Personal was a major milestone for us and, importantly, spinal cord injury (“SCI”) patients, allowing those covered by Medi
Show less
Read more
Impact Snapshot
Event Time:
EKSO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
EKSO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
EKSO alerts
High impacting Ekso Bionics Holdings, Inc. news events
Weekly update
A roundup of the hottest topics
EKSO
News
- Ekso Bionics Holdings, Inc. (NASDAQ: EKSO) had its price target lowered by analysts at Lake Street Capital from $2.50 to $2.00. They now have a "buy" rating on the stock.MarketBeat
- Ekso Bionics Holdings, Inc. (NASDAQ: EKSO) had its price target lowered by analysts at HC Wainwright from $10.00 to $9.00. They now have a "buy" rating on the stock.MarketBeat
- Ekso Bionics Holdings Q3 Earnings Preview [Seeking Alpha]Seeking Alpha
- Ekso Bionics Holdings, Inc. (NASDAQ: EKSO) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.MarketBeat
- Ekso Bionics to Report Third Quarter 2024 Financial Results on October 28, 2024GlobeNewswire
EKSO
Earnings
- 10/28/24 - Miss
EKSO
Sec Filings
- 10/28/24 - Form 10-Q
- 10/28/24 - Form 8-K
- 9/12/24 - Form SCHEDULE
- EKSO's page on the SEC website